Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CD45RA-depleted DLI for the Prevention of Viral Infections After Transplantation
NCT07672964Phase 1Not yet recruiting
- Sponsor
- Ruijin Hospital
- Start
- Jul 2026
- Primary completion
- Jul 2027
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of CD45RA depleted donor lymphocyte infusion in viral infection, sponsored by Ruijin Hospital. Primary endpoint: Cumulative Incidence of Overall Viral Infection at 90 days. Planned start Jul 2026; status: not yet recruiting.
02
Drugs
CD45RA depleted donor lymphocyte infusion
03
Conditions
viral infection
Beyond the preview
Go deeper on NCT07672964.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07672964.